Gene · 23152
Papers1,814
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,814
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer. | Front Oncol | 2023 | 38023196 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| The Contribution of Mediastinal Transbronchial Nodal Cryobiopsy to Morpho-Histological and Molecular Diagnosis. | Diagnostics (Basel) | 2023 | 37998611 | PubTator, text mining | PubMed |
| CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer. | Cancer Res | 2023 | 37934115 | PubTator, text mining | PubMed |
| Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting. | Acta Neuropathol Commun | 2023 | 37932833 | PubTator, text mining | PubMed |
| Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study. | Elife | 2023 | 37929934 | PubTator, text mining | PubMed |
| IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. | Front Immunol | 2023 | 37928523 | PubTator, text mining | PubMed |
| Molecular and clinical characterization of ANG expression in gliomas and its association with tumor-related immune response. | Front Med (Lausanne) | 2023 | 37928479 | PubTator, text mining | PubMed |
| Cancer of unknown primary histologically, genetically and spatially diagnosed as left ovary‑derived cancer: A case report. | Oncol Lett | 2023 | 37927414 | PubTator, text mining | PubMed |
| Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects. | Front Mol Biosci | 2023 | 37908227 | PubTator, text mining | PubMed |
| Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials. | Chin Med | 2023 | 37907925 | PubTator, text mining | PubMed |
| The genetic evolution of acral melanoma. | bioRxiv | 2023 | 37904969 | PubTator, text mining | PubMed |
| First Female Patient with a Rare CIC-FOXO4-Translocated Sarcoma: A Case Report. | Case Rep Oncol | 2023 | 37900856 | PubTator, text mining | PubMed |
| Autoantibody Diversity Is Augmented in Women with Breast Cancer and Is Related to the Stage of the Disease. | Curr Oncol | 2023 | 37887534 | PubTator, text mining | PubMed |
| Muscle-invasive angiosarcoma of the urinary bladder: Case report. | Urol Case Rep | 2023 | 37886347 | PubTator, text mining | PubMed |
| Cognitive Dysfunction in Patients Treated with Androgen Deprivation Therapy: A Multimodality Functional Imaging Study to Evaluate Neuroinflammation. | Prostate Cancer | 2023 | 37885823 | PubTator, text mining | PubMed |
| A Practical Approach to Small Round Cell Tumors Involving the Gastrointestinal Tract and Abdomen. | Surg Pathol Clin | 2023 | 37863565 | PubTator, text mining | PubMed |
| Regulation of gene expression downstream of a novel Fgf/Erk pathway during Xenopus development. | PLoS One | 2023 | 37856433 | PubTator, text mining | PubMed |
| Functional implications of paralog genes in polyglutamine spinocerebellar ataxias. | Hum Genet | 2023 | 37845370 | PubTator, text mining | PubMed |
| CIC-DUX4 Sarcoma Involving the Skull Base: A Rare Presentation and Review of the Literature. | J Neurol Surg Rep | 2023 | 37842548 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23152/papers?page=12